About this Webinar
With improved outlooks for multiple conditions, GLP-1s continue to make headlines, but these advances don’t come without financial risks. In this session, Employers Health’s resident GLP-1 experts Courtney Keefe and Kevin Wenceslao will cover:
- Recent key developments in GLP-1s, including treatment guidelines, indications, package labeling and shortages;
- A snapshot of the Employers Health book of business coverage decisions, trends, drug mix and adherence;
- Emerging studies and future developments around the GLP-1 landscape.